These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3877257)

  • 21. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC; Burns RS; Markey SP; Jacobowitz DM; Kopin IJ
    Life Sci; 1985 Jan; 36(3):213-8. PubMed ID: 3871241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
    Rouillard C; Bédard PJ; Di Paolo T
    Eur J Pharmacol; 1990 Aug; 185(2-3):209-15. PubMed ID: 2253695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS; Yuwiler A; Markham CH
    Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion.
    Bankiewicz KS; Oldfield EH; Plunkett RJ; Schuette WH; Cogan DG; Hogan N; Zuddas A; Kopin IJ
    Brain Res; 1991 Feb; 541(1):98-102. PubMed ID: 2029630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K; Kondo T; Narabayashi H
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.
    Schneider JS; Yuwiler A; Markham CH
    Exp Neurol; 1986 Feb; 91(2):293-307. PubMed ID: 3484707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
    Grondin R; Bédard PJ; Britton DR; Shiosaki K
    Neurology; 1997 Aug; 49(2):421-6. PubMed ID: 9270571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP.
    Brooks BA; Eidelberg E; Morgan WW
    Brain Res; 1987 Sep; 419(1-2):329-32. PubMed ID: 3499952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Burns RS; Chiueh CC; Markey SP; Ebert MH; Jacobowitz DM; Kopin IJ
    Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4546-50. PubMed ID: 6192438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].
    Degryse AD; Colpaert FC
    Brain Res Bull; 1986 May; 16(5):561-71. PubMed ID: 3488798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Close SP; Marriott AS; Pay S
    Br J Pharmacol; 1985 Jun; 85(2):320-2. PubMed ID: 3928007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saccade responses to dopamine in human MPTP-induced parkinsonism.
    Hotson JR; Langston EB; Langston JW
    Ann Neurol; 1986 Oct; 20(4):456-63. PubMed ID: 3491578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
    Jenner P; Rupniak NM; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):85-90. PubMed ID: 6436758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
    Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL
    Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Life Sci; 1987 Apr; 40(17):1657-64. PubMed ID: 3494179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Bankiewicz KS; Oldfield EH; Chiueh CC; Doppman JL; Jacobowitz DM; Kopin IJ
    Life Sci; 1986 Jul; 39(1):7-16. PubMed ID: 3487691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.